ALEJANDRO ARROLIGA to Hypertension, Pulmonary
This is a "connection" page, showing publications ALEJANDRO ARROLIGA has written about Hypertension, Pulmonary.
Connection Strength
2.232
-
Predictors of nocturnal oxygen desaturation in pulmonary arterial hypertension. Chest. 2007 Jan; 131(1):109-17.
Score: 0.195
-
Long-term results after addition of sildenafil in idiopathic PAH patients on bosentan. South Med J. 2006 Aug; 99(8):880-3.
Score: 0.189
-
Surgical intervention in patients with moderate to severe pulmonary arterial hypertension. Conn Med. 2006 Apr; 70(4):239-43.
Score: 0.185
-
Hypothyroidism and pulmonary arterial hypertension. Am J Med. 2004 Mar 01; 116(5):354-5.
Score: 0.160
-
Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension. Drugs Today (Barc). 2004 Mar; 40(3):225-34.
Score: 0.160
-
Association between hyperhomocysteinemia and primary pulmonary hypertension. Respir Med. 2003 Jul; 97(7):825-9.
Score: 0.153
-
Nocturnal hypoxemia is common in primary pulmonary hypertension. Chest. 2001 Sep; 120(3):894-9.
Score: 0.135
-
Primary pulmonary hypertension and thyroid disease. Chest. 2000 Oct; 118(4):1224-5.
Score: 0.126
-
Primary pulmonary hypertension: update on pathogenesis and novel therapies. Cleve Clin J Med. 2000 Mar; 67(3):175-8, 181-5, 189-90.
Score: 0.121
-
High prevalence of hypothyroidism in patients with primary pulmonary hypertension. Am J Med Sci. 1999 Nov; 318(5):289-92.
Score: 0.119
-
Airway responsiveness to inhaled albuterol in patients with pulmonary hypertension. Clin Pediatr (Phila). 1999 Jan; 38(1):27-33.
Score: 0.112
-
Manifestations of scleroderma pulmonary disease. Clin Chest Med. 1998 Dec; 19(4):713-31, viii-ix.
Score: 0.111
-
Circulating miRNAs as potential marker for pulmonary hypertension. PLoS One. 2013; 8(5):e64396.
Score: 0.076
-
Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension. Clin Transl Sci. 2008 Sep; 1(2):99-106.
Score: 0.055
-
Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia. Chest. 2007 Apr; 131(4):984-7.
Score: 0.050
-
Nitric oxide and pulmonary arterial pressures in pulmonary hypertension. Free Radic Biol Med. 2004 Oct 01; 37(7):1010-7.
Score: 0.042
-
Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J. 2004 Nov; 18(14):1746-8.
Score: 0.042
-
Diagnosis and evaluation of pulmonary hypertension. Cleve Clin J Med. 2003 Apr; 70 Suppl 1:S9-17.
Score: 0.038
-
Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension. Cleve Clin J Med. 2003 Apr; 70 Suppl 1:S18-27.
Score: 0.038
-
Circulating monocytes from patients with primary pulmonary hypertension are hyporesponsive. Clin Immunol. 2002 Aug; 104(2):191-8.
Score: 0.036
-
High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy. Lung. 2001; 179(4):233-43.
Score: 0.032
-
Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am J Respir Crit Care Med. 1998 Sep; 158(3):917-23.
Score: 0.027
-
Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci U S A. 2007 Jan 23; 104(4):1342-7.
Score: 0.012
-
Exacerbation of underlying pulmonary disease in pregnancy. Crit Care Med. 2005 Oct; 33(10 Suppl):S313-8.
Score: 0.011
-
Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages. Am J Respir Cell Mol Biol. 1999 Sep; 21(3):311-6.
Score: 0.007